BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 32627866)

  • 1. MicroRNA-92b acts as an oncogene by targeting PTEN/AKT in NSCLC.
    Guo JH; Fang HY; Yang JM; Liu SL; Yao QH; Fan YJ; Zhao M; Liu F; Zhang QW; Gao FH
    Cell Biochem Funct; 2020 Dec; 38(8):1100-1110. PubMed ID: 32627866
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MicroRNA-92a promotes epithelial-mesenchymal transition through activation of PTEN/PI3K/AKT signaling pathway in non-small cell lung cancer metastasis.
    Lu C; Shan Z; Hong J; Yang L
    Int J Oncol; 2017 Jul; 51(1):235-244. PubMed ID: 28534966
    [TBL] [Abstract][Full Text] [Related]  

  • 3. miR-92b regulates glioma cells proliferation, migration, invasion, and apoptosis via PTEN/Akt signaling pathway.
    Song H; Zhang Y; Liu N; Wan C; Zhang D; Zhao S; Kong Y; Yuan L
    J Physiol Biochem; 2016 Jun; 72(2):201-11. PubMed ID: 26893028
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MicroRNA-25-3p promotes cisplatin resistance in Non-small-cell lung carcinoma (NSCLC) through adjusting PTEN/PI3K/AKT route.
    Sun B; Hu N; Cong D; Chen K; Li J
    Bioengineered; 2021 Dec; 12(1):3219-3228. PubMed ID: 34266345
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MicroRNA-103a-3p Promotes Cell Proliferation and Invasion in Non-Small-Cell Lung Cancer Cells through Akt Pathway by Targeting PTEN.
    Li H; Huhe M; Lou J
    Biomed Res Int; 2021; 2021():7590976. PubMed ID: 34307670
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dual roles of miR-374a by modulated c-Jun respectively targets CCND1-inducing PI3K/AKT signal and PTEN-suppressing Wnt/β-catenin signaling in non-small-cell lung cancer.
    Zhao M; Xu P; Liu Z; Zhen Y; Chen Y; Liu Y; Fu Q; Deng X; Liang Z; Li Y; Lin X; Fang W
    Cell Death Dis; 2018 Jan; 9(2):78. PubMed ID: 29362431
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MicroRNA-4286 promotes cell proliferation, migration, and invasion via PTEN regulation of the PI3K/Akt pathway in non-small cell lung cancer.
    Ling C; Wang X; Zhu J; Tang H; Du W; Zeng Y; Sun L; Huang JA; Liu Z
    Cancer Med; 2019 Jul; 8(7):3520-3531. PubMed ID: 31074594
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MiR-4299 suppresses non-small cell lung cancer cell proliferation, migration and invasion through modulating PTEN/AKT/PI3K pathway.
    Yang WB; Zhang WP; Shi JL; Wang JW
    Eur Rev Med Pharmacol Sci; 2018 Jun; 22(11):3408-3414. PubMed ID: 29917192
    [TBL] [Abstract][Full Text] [Related]  

  • 9. miR-205 targets PTEN and PHLPP2 to augment AKT signaling and drive malignant phenotypes in non-small cell lung cancer.
    Cai J; Fang L; Huang Y; Li R; Yuan J; Yang Y; Zhu X; Chen B; Wu J; Li M
    Cancer Res; 2013 Sep; 73(17):5402-15. PubMed ID: 23856247
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of microRNA-135a on Cell Proliferation, Migration, Invasion, Apoptosis and Tumor Angiogenesis Through the IGF-1/PI3K/Akt Signaling Pathway in Non-Small Cell Lung Cancer.
    Zhou Y; Li S; Li J; Wang D; Li Q
    Cell Physiol Biochem; 2017; 42(4):1431-1446. PubMed ID: 28715819
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MiR-92b-3p promotes neurite growth and functional recovery via the PTEN/AKT pathway in acute spinal cord injury.
    Chen Z; Li Z; Jiang C; Jiang X; Zhang J
    J Cell Physiol; 2019 Dec; 234(12):23043-23052. PubMed ID: 31120592
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long non‑coding RNA MEG3 inhibits cell migration and invasion of non‑small cell lung cancer cells by regulating the miR‑21‑5p/PTEN axis.
    Lv D; Bi Q; Li Y; Deng J; Wu N; Hao S; Zhao M
    Mol Med Rep; 2021 Mar; 23(3):. PubMed ID: 33495842
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Involvement of miR-4262 in paclitaxel resistance through the regulation of PTEN in non-small cell lung cancer.
    Sun H; Zhou X; Bao Y; Xiong G; Cui Y; Zhou H
    Open Biol; 2019 Jul; 9(7):180227. PubMed ID: 31337279
    [TBL] [Abstract][Full Text] [Related]  

  • 14. miR-1297 Promotes Cell Proliferation of Non-Small Cell Lung Cancer Cells: Involving in PTEN/Akt/Skp2 Signaling Pathway.
    Bu W; Luo T
    DNA Cell Biol; 2017 Nov; 36(11):976-982. PubMed ID: 28872922
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Deregulation of lncRNA-AC078883.3 and microRNA-19a is involved in the development of chemoresistance to cisplatin via modulating signaling pathway of PTEN/AKT.
    Xing S; Qu Y; Li C; Huang A; Tong S; Wu C; Fan K
    J Cell Physiol; 2019 Dec; 234(12):22657-22665. PubMed ID: 31111480
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MiR-92b regulates the cell growth, cisplatin chemosensitivity of A549 non small cell lung cancer cell line and target PTEN.
    Li Y; Li L; Guan Y; Liu X; Meng Q; Guo Q
    Biochem Biophys Res Commun; 2013 Nov; 440(4):604-10. PubMed ID: 24099768
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enforced expression of miR-92b blunts
    Jiang K; Yang J; Song C; He F; Yang L; Li X
    Int J Biol Sci; 2021; 17(5):1289-1301. PubMed ID: 33867846
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MiRNA-10a is upregulated in NSCLC and may promote cancer by targeting PTEN.
    Yu T; Liu L; Li J; Yan M; Lin H; Liu Y; Chu D; Tu H; Gu A; Yao M
    Oncotarget; 2015 Oct; 6(30):30239-50. PubMed ID: 26317552
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tumor-suppressive effects of microRNA-181d-5p on non-small-cell lung cancer through the CDKN3-mediated Akt signaling pathway in vivo and in vitro.
    Gao LM; Zheng Y; Wang P; Zheng L; Zhang WL; Di Y; Chen LL; Yin XB; Tian Q; Shi SS; Xu SF
    Am J Physiol Lung Cell Mol Physiol; 2019 May; 316(5):L918-L933. PubMed ID: 30628487
    [TBL] [Abstract][Full Text] [Related]  

  • 20. miR-106a promotes growth and metastasis of non-small cell lung cancer by targeting PTEN.
    Xie X; Liu HT; Mei J; Ding FB; Xiao HB; Hu FQ; Hu R; Wang MS
    Int J Clin Exp Pathol; 2015; 8(4):3827-34. PubMed ID: 26097565
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.